Kodein

Codeine, the active ingredient in Kodein, is an opioid analgesic presented as an oral dosage form for oral use. It is employed to relieve mild to moderate pain and to suppress cough in adult patients when other treatments are insufficient. It acts centrally on the nervous system and is available by prescription in the European Union.

GNH USA supplies Kodein as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across multiple regions.

Codeine is an opioid analgesic used in the management of pain and cough.

- Mild to moderate pain: provides analgesia to reduce discomfort. - Acute cough: suppresses the cough reflex to improve breathing comfort. - Post‑operative discomfort: alleviates short‑term pain after minor procedures.

Codeine may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Constipation: reduced bowel motility. - Drowsiness: increased sleepiness. - Dizziness: sensation of light‑headedness. - Dry mouth: reduced salivation. - Vomiting: occasional emesis.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing, potentially life‑threatening. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Dependence or addiction: risk with prolonged use. - Low blood pressure: hypotensive episodes. - Seizures: rare neurologic events.

When prescribing or dispensing Codeine, consider the following precautions.

- Assess renal and hepatic function: adjust use in impairment. - Avoid in children under 12 years: not recommended for this age group. - Do not combine with CNS depressants: increased sedation and respiratory risk. - Use caution in pregnancy: potential fetal risk, consult obstetric guidance. - Monitor for signs of dependence: limit duration and dosage. - Store at ambient temperature: keep in the original pack, protect from moisture.

Codeine can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Alcohol: additive central nervous system depression. - Benzodiazepines: heightened risk of respiratory depression. - MAO inhibitors: possible severe hypotension. - Other opioid analgesics: additive effect leading to overdose. - CYP2D6 inhibitors: increased plasma concentrations of codeine.

Moderate Interactions (Monitor Closely): - Antihistamines: may increase drowsiness. - SSRIs or SNRIs: rare risk of serotonin syndrome. - Diuretics: potential enhancement of hypotensive effect.